CRP and rheumatoid arthritis: Specifically, MEDI8968 demonstrated statistically significant higher scores in ACR20/50 (20/50% improvement in American College of Rheumatology criteria) and Disease Activity Score 28–CRP protein compared with placebo in subjects with rheumatoid arthritis, but responses were weak or absent in swollen joints count and physician and patient global assessments [16].